Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
EVP & GENERAL COUNSEL · UNITED THERAPEUTICS Corp · Common Stock
Option exercise — administrative, little informational value
$1.2M reported value · 18.4% of prior position
Disclosed 0 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $70K 120 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $182K 310 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $48K 80 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $407K 720 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $127K 221 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $95K 160 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $180K 320 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $193K 330 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $311K 539 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $139K 240 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $47K 80 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $184K 320 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $159K 280 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $334K 585 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $166K 280 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $93K 160 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $262K 462 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $24K 40 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $100K 167 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $142K 237 sh | Nov 6, 2026 traded Nov 5, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $1,212,049
Mahon Paul A filed this Form 4 reporting a option exercise of UTHR on Nov 5, 2026. It became public on Nov 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.